At this time, the entrance of Shaocheng People's Hospital was full of people.

Among them, there is a group of people, headed by Sun Yangping.

They are all family members of Shaocheng People's Hospital, the subjects of the phase I clinical trial.

They each carried a small flag and a banner with words of thanks to the Morning Moon creatures.

This is to thank the medicine produced by Chenyue Biotech for completely curing their family's illness.

They had been thinking about thanking Zhang Chen.

When he first received the news, Zhang Chen refused, but he couldn't resist the kindness of the patient's family.

In the end, after negotiation, they were willing to use this way to promote this drug of Chenyue Biology.

"Shura Warrior God"

In their eyes, it is a miracle medicine that cures the sick and saves people.

We need to increase publicity so that more people know about it, so that more people can be saved.

The other group of people are reporters from various media that Zhang Yue made appointments with in advance.

Among them, Zhao Lingli of Xinlang is naturally indispensable.

Since you have decided to do publicity, you have to do your best to do your best.

Zhang Yue not only found various media in advance, but also arranged her own company's live broadcast.

Up to now, Chenyue Bio's Douyin live broadcast has tens of millions of fans, which can be regarded as an out-and-out Internet celebrity live broadcast room.

At this time, the media reporters were interviewing the families of the patients one by one.

The patient's family was also very cooperative.

What kind of disease did your family have, what kind of treatment did you get after being tested, and how your condition recovered after being administered.

They told this information to the camera without reservation.

The gratitude of the Morning Moon creatures is from the bottom of their hearts.

Therefore, they chose to spare no effort to help Chenyue Biotech do a good job of publicity.

Shortly after the interview.

A business vehicle slowly stopped at the entrance of the hospital.

Zhang Chen and Zhang Yue walked out of the car hand in hand.

Seeing the symptoms in front of him, Zhang Chen was slightly stunned.

He knew that patients in the Phase 1 clinical trial would give them publicity.

But not at all expected that it would be in such a way.

Originally, he planned not to appear on the public screen as much as possible.

He just wants to do his own research quietly, and learn the habit that seems to never be finished.

But today, he seems to have to face this situation.

However, in order to publicize Lanyue 001 and let more people know about the existence of this drug, it is still necessary for him to show up appropriately.

Thinking of this, Zhang Chen came to everyone generously and greeted him warmly.

The family members of the patients all said words of gratitude, and some even couldn't control their emotions, and burst into tears for a while, and the scene was very touching.

Zhang Chen looked at the scene in front of him, and he thought to himself, this is probably the reason why many people are desperately trying to develop new drugs.

Nowadays, many innovative drugs have indeed brought hope and hope to some patients.

Especially those with rare diseases, they face the dilemma of having no cure.

There is simply no way in the world to cure their disease completely.

They can only be deeply troubled, counting down in despair day by day.

People who have not experienced this kind of mood cannot empathize at all.

When Zhang Chen was in the first phase of clinical trials, he encountered several cases of such patients.

Although cardiovascular-related diseases are not rare, they have not reached the point where there is no cure.

However, the condition of some patients is very unoptimistic, if only some conventional chemical drugs are used, not to say that there is no effect, but only slightly alleviate the symptoms.

And the price of these drugs is actually not cheap.

If people with health insurance are okay, people without health insurance are really desperate.

But it was at this time that Zhang Chen brought them hope.

Especially like Sun Yangping's father, he suddenly had a large-scale cerebral infarction.

At that time, the situation was very critical, but fortunately he met Zhang Chen at the gate of the hospital, and fortunately, Sun Yangping chose to believe him at that time.

Zhang Chen saw that everyone was more emotional, he raised his hand and said, "You don't have to be like this, this medicine can have such a good effect, and I am willing to see it."

This is my original intention to produce usable drugs and easy to use medicines, and in the future, Chenyue Biology will develop more innovative drugs to completely eliminate all human diseases, which is not an unattainable thing, at least for now, we can completely eliminate cardiovascular related diseases. ”

After Zhang Chen finished speaking, thunderous applause rang out at the scene.

"Mr. Zhang, I support you, in the future, if your company's medicine still needs clinical subjects, I will be the first to sign up."

"Mr. Zhang, I see that your company seems to be very professional products in addition to shampoo, and when will you launch some that everyone can use, we will also support a wave."

"Mr. Zhang, I also support you, I believe that one day, the Morning Moon Creatures will definitely be able to eliminate all diseases."

Zhang Chen smiled and nodded in satisfaction.

This is the effect he wants, and he is sincerely happy to be recognized by some people.

However, it's time to make some more products like shampoo that can popularize life.

And if the first drug can get such good feedback, then when a new drug is launched in the future, there will definitely be better results.

There are not only family members of patients, but also some subjects who have been introduced and want to participate in clinical trials.

Zhang Chen asked Zhang Yue to stay and help them register their information.

Now that the number of clinical subjects in the second phase has been exhausted, these people can only be arranged to the third phase.

However, the phase II clinical trial lasted for a short time, and if everything went well, it would only take five days to finish.

According to the previous plan, 800 phase II clinical subjects will be recruited nationwide, and clinical trials will be conducted by eight hospitals at the same time.

This results in an average of 100 participants per hospital.

If it's a little faster, 20 subjects are injected per day, which is no problem at all.

In this way, the phase II clinical trial can be completed in five days.

After greeting everyone, Zhang Chen asked "Commander No. 1" to accompany him to help Zhang Yue register the subject.

He, Tian Wenbin, and Jiang Lu rushed straight to the inpatient department.

As planned, 20 subjects were scheduled today.

In the first phase of the clinical trial, only 15 subjects were arranged on the last day.

So today's clinical trial of 20 subjects is a little bit tight.

So much so that Zhang Chen couldn't do everything, and he couldn't wait for half an hour in every ward.

He only chose to wait for the results to come out in the first 10 minutes, and when he was sure that there was no problem with the results, he rushed directly to the next patient's room.

Tian Wenbin and Jiang Lu were also separated, and one person was responsible for observing the clinical examination results of 10 subjects.

After Zhang Yue dealt with the outside affairs, she returned to Zhang Chen's side.

Half an hour later.

It is still Xinlang who is the first to issue today's interview news.

At this time, it was far away in a luxury villa in the capital.

A middle-aged man with his hair combed on his back and wearing a delicate suit looked at the mobile phone news with displeasure in his eyes.

He said viciously: "If you want to go public smoothly, it's not that easy. ”